PCA
ABBV icon

Prosperity Capital Advisors’s AbbVie ABBV Stock Holding History

Prosperity Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.1M Sell
20,281
-2,158
-10% -$464K 0.25% 72
2026
Q1 		$4.88M Buy
22,439
+2,117
+10% +$470K 0.28% 71
2025
Q4 		$4.64M Sell
20,322
-8,610
-30% -$1.96M 0.28% 76
2025
Q3 		$6.7M Sell
28,932
-427
-1% -$87K 0.39% 50
2025
Q2 		$5.45M Buy
29,359
+7,772
+36% +$1.44M 0.36% 53
2025
Q1 		$4.45M Buy
21,587
+585
+3% +$114K 0.35% 54
2024
Q4 		$3.73M Sell
21,002
-292
-1% -$53.7K 0.3% 64
2024
Q3 		$4.21M Buy
21,294
+14,628
+219% +$2.73M 0.36% 55
2024
Q2 		$1.14M Sell
6,666
-14,160
-68% -$2.35M 0.13% 123
2024
Q1 		$3.79M Buy
20,826
+2,515
+14% +$433K 0.45% 39
2023
Q4 		$2.84M Buy
18,311
+78
+0.4% +$11.4K 0.31% 49
2023
Q3 		$2.72M Buy
18,233
+571
+3% +$83.8K 0.36% 49
2023
Q2 		$2.38M Buy
17,662
+895
+5% +$131K 0.33% 55
2023
Q1 		$2.67M Buy
16,767
+67
+0.4% +$10.2K 0.41% 48
2022
Q4 		$2.7M Buy
+16,700
New +$2.56M 0.83% 18

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Prosperity Capital Advisors's ABBV Position: Q2 2026 in Review

Prosperity Capital Advisors reduced its AbbVie (ABBV) stake by 9.6% in Q2 2026, selling an estimated $464K and leaving 20,281 shares worth $5.1M. The position accounts for 0.25% of the portfolio, ranked #72.

Prosperity Capital Advisors first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. The position peaked at $6.7M in Q3 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Prosperity Capital Advisors held 20,281 shares of AbbVie worth $5.1M as of Q2 2026.
  • Prosperity Capital Advisors sold 2,158 AbbVie shares in Q2 2026, an estimated $464K.
  • AbbVie made up 0.25% of Prosperity Capital Advisors's portfolio in Q2 2026, its #72 holding.
  • Prosperity Capital Advisors first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • Prosperity Capital Advisors's AbbVie position peaked at $6.7M in Q3 2025.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Prosperity Capital Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.